Ac Immune Stock Performance
| ACIU Stock | USD 2.37 0.01 0.42% |
The firm owns a Beta (Systematic Risk) of 1.17, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, AC Immune will likely underperform. AC Immune has an expected return of -0.52%. Please make sure to confirm AC Immune potential upside, and the relationship between the jensen alpha and rate of daily change , to decide if AC Immune performance from the past will be repeated sooner or later.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days AC Immune has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain comparatively stable which may send shares a bit higher in May 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
Actual Historical Performance (%)
One Day Return 0.84 | Five Day Return (0.42) | Year To Date Return (49.04) | Ten Year Return (84.74) | All Time Return (84.74) |
1 | Down -35.7 percent in 4 Weeks, Heres Why AC Immune Looks Ripe for a Turnaround | 01/30/2024 |
2 | AbbVie Announces Appointment of New CEO Robert Michael | 02/21/2024 |
3 | Catalyst Watch Jobs report, Powell treks to Congress, Target earnings | 03/01/2024 |
4 | AC Immune files 350M mixed securities shelf | 03/14/2024 |
5 | We Think AC Immune Can Afford To Drive Business Growth | 03/15/2024 |
6 | Should You Add AC Immune SA Stock to Your Portfolio Tuesday - InvestorsObserver | 03/26/2024 |
7 | AC Immune SA May Have Run Too Fast Too Soon With Recent 30 percent Price Plummet | 04/05/2024 |
8 | AC Immune Reports Q2 Loss, Lags Revenue Estimates - Yahoo Movies Canada | 04/15/2024 |
| Begin Period Cash Flow | 31.6 M |
ACIU |
AC Immune Relative Risk vs. Return Landscape
If you would invest 352.00 in AC Immune on January 26, 2024 and sell it today you would lose (115.00) from holding AC Immune or give up 32.67% of portfolio value over 90 days. AC Immune is currently does not generate positive expected returns and assumes 4.5526% risk (volatility on return distribution) over the 90 days horizon. In different words, 40% of stocks are less volatile than ACIU, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
AC Immune Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for AC Immune's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as AC Immune, and traders can use it to determine the average amount a AC Immune's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.115
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ACIU |
Estimated Market Risk
| 4.55 actual daily | 40 60% of assets are more volatile |
Expected Return
| -0.52 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average AC Immune is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AC Immune by adding AC Immune to a well-diversified portfolio.
AC Immune Fundamentals Growth
ACIU Stock prices reflect investors' perceptions of the future prospects and financial health of AC Immune, and AC Immune fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ACIU Stock performance.
| Return On Equity | -0.33 | ||||
| Return On Asset | -0.18 | ||||
| Operating Margin | (0.24) % | ||||
| Current Valuation | 123.12 M | ||||
| Shares Outstanding | 98.9 M | ||||
| Price To Earning | (16.96) X | ||||
| Price To Book | 1.55 X | ||||
| Price To Sales | 18.31 X | ||||
| Revenue | 14.8 M | ||||
| Gross Profit | (56.4 M) | ||||
| EBITDA | (50.37 M) | ||||
| Net Income | (54.23 M) | ||||
| Cash And Equivalents | 154.15 M | ||||
| Cash Per Share | 1.83 X | ||||
| Total Debt | 3.5 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 13.28 X | ||||
| Book Value Per Share | 1.71 X | ||||
| Cash Flow From Operations | (60.41 M) | ||||
| Earnings Per Share | (0.70) X | ||||
| Market Capitalization | 229.45 M | ||||
| Total Asset | 182.81 M | ||||
| Retained Earnings | (316.2 M) | ||||
| Working Capital | 111.58 M | ||||
| Current Asset | 160 M | ||||
| Current Liabilities | 11 M | ||||
About AC Immune Performance
To evaluate AC Immune Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when AC Immune generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare ACIU Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand AC Immune market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents ACIU's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (4.16) | (4.37) | |
| Return On Tangible Assets | (0.41) | (0.39) | |
| Return On Capital Employed | (0.32) | (0.30) | |
| Return On Assets | (0.30) | (0.28) | |
| Return On Equity | (0.34) | (0.32) |
Things to note about AC Immune performance evaluation
Checking the ongoing alerts about AC Immune for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for AC Immune help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| AC Immune generated a negative expected return over the last 90 days | |
| AC Immune has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 14.8 M. Net Loss for the year was (54.23 M) with loss before overhead, payroll, taxes, and interest of (56.4 M). | |
| AC Immune currently holds about 154.15 M in cash with (60.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.83. | |
| AC Immune has a poor financial position based on the latest SEC disclosures | |
| Roughly 42.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: AC Immune Reports Q2 Loss, Lags Revenue Estimates - Yahoo Movies Canada |
- Analyzing AC Immune's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether AC Immune's stock is overvalued or undervalued compared to its peers.
- Examining AC Immune's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating AC Immune's management team can have a significant impact on its success or failure. Reviewing the track record and experience of AC Immune's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of AC Immune's stock. These opinions can provide insight into AC Immune's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AC Immune. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy ACIU Stock please use our How to Invest in AC Immune guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for ACIU Stock analysis
When running AC Immune's price analysis, check to measure AC Immune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AC Immune is operating at the current time. Most of AC Immune's value examination focuses on studying past and present price action to predict the probability of AC Immune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AC Immune's price. Additionally, you may evaluate how the addition of AC Immune to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stocks Directory Find actively traded stocks across global markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |
Is AC Immune's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AC Immune. If investors know ACIU will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AC Immune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.70) | Revenue Per Share 0.175 | Quarterly Revenue Growth 14.8 K | Return On Assets (0.18) | Return On Equity (0.33) |
The market value of AC Immune is measured differently than its book value, which is the value of ACIU that is recorded on the company's balance sheet. Investors also form their own opinion of AC Immune's value that differs from its market value or its book value, called intrinsic value, which is AC Immune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AC Immune's market value can be influenced by many factors that don't directly affect AC Immune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AC Immune's value and its price as these two are different measures arrived at by different means. Investors typically determine if AC Immune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AC Immune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.